What it's for (Indications)
- Eperisone hydrochloride is indicated for the symptomatic treatment of various conditions associated with muscle spasm and spasticity.
- These include, but are not limited to, cervicobrachial syndrome, periarthritis of the shoulder, and lumbago, where muscle hypertonicity contributes significantly to pain and restricted movement.
- It is also utilized for the improvement of spastic paralysis in neurological disorders such as cerebral palsy, spastic spinal paralysis, cerebrovascular disease sequelae, cervical spondylosis, post-operative sequelae (e.
- g.
- , of brain tumor), traumatic sequelae (e.
- g.
- , spinal cord injury, head injury), and amyotrophic lateral sclerosis.
- The therapeutic goal is to alleviate muscle stiffness, improve motor function, and reduce associated pain.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The typical adult oral dosage for eperisone hydrochloride is 50 mg administered three times daily, after meals. Dosage adjustments may be necessary based on the patient's age, the severity of symptoms, and individual tolerance to the medication. For elderly patients or those with pre-existing hepatic or renal impairment, a reduced starting dose and careful titration under medical supervision may be warranted to mitigate the risk of adverse effects. It is crucial to emphasize that this medication should always be taken exactly as prescribed by a healthcare professional, and the dosage should not be altered without prior consultation. The maximum daily dose should not exceed 150 mg without specific medical direction. Adherence to the prescribed regimen is vital for optimal therapeutic outcomes and safety. |
Safety & Warnings
Common Side Effects
- Eperisone is generally well-tolerated, but like all medications, it can cause adverse effects.
- Common side effects often include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, diarrhea, or constipation, along with dry mouth.
- Central nervous system effects may manifest as dizziness, lightheadedness, drowsiness, headache, or insomnia.
- Musculoskeletal complaints, including weakness or numbness in the extremities, have also been reported.
- Less common but potentially more serious adverse reactions can include liver dysfunction (evidenced by elevated liver enzymes), kidney dysfunction, and hematological abnormalities.
- Hypersensitivity reactions, such as skin rashes, pruritus, or urticaria, may occur and, in rare instances, severe anaphylactic reactions have been documented.
- Patients should be advised to promptly report any new or worsening symptoms to their healthcare provider for appropriate evaluation and management, particularly if experiencing signs of allergic reaction, severe dizziness, or significant changes in liver function.
Serious Warnings
- Black Box Warning: Eperisone hydrochloride does not carry a formal FDA-style Black Box Warning. However, healthcare professionals and patients should be aware of several **Serious Warnings** associated with its use. There is a potential for severe hypersensitivity reactions, including anaphylaxis, which can be life-threatening. Patients should be counseled to immediately discontinue the medication and seek emergency medical attention if they experience symptoms such as difficulty breathing, swelling of the face, lips, tongue, or throat, or a generalized severe rash. Furthermore, caution is advised in patients with pre-existing hepatic or renal impairment, as the drug's metabolism and excretion may be compromised, leading to increased systemic exposure and an elevated risk of adverse effects, including hepatic enzyme elevations or renal function deterioration; regular monitoring of liver and kidney function tests is recommended in such individuals. The drug can cause central nervous system depression, including drowsiness and dizziness, which may impair a patient's ability to operate machinery or drive. Concomitant use with alcohol or other central nervous system depressants may exacerbate these effects and should be avoided or closely monitored. The safety and efficacy of eperisone in pediatric populations have not been definitively established, and its use in children is generally not recommended.
- Patients receiving eperisone hydrochloride should be cautioned regarding potential impairment of their ability to perform tasks requiring mental alertness, such as operating heavy machinery or driving a vehicle, especially during the initial phase of treatment or following dosage adjustments, due to the risk of dizziness and drowsiness.
- This medication should be used with extreme caution in individuals with pre-existing hepatic or renal impairment, as drug accumulation may occur, increasing the risk of adverse effects; close monitoring of liver and kidney function is advisable in these patient populations.
- Elderly patients are generally more susceptible to adverse reactions, including central nervous system effects, and therefore require careful dosage titration and monitoring.
- Concomitant use with other central nervous system depressants, including alcohol, sedatives, hypnotics, or other muscle relaxants, may potentiate the sedative effects and should be approached with caution.
- Patients should be advised to discontinue eperisone and seek immediate medical attention if they experience any signs of a severe hypersensitivity reaction, such as swelling of the face or throat, difficulty breathing, or severe skin rash, as anaphylaxis is a rare but serious potential adverse event.
How it Works (Mechanism of Action)
Eperisone hydrochloride is a centrally acting muscle relaxant that exerts its therapeutic effects through a complex interplay of mechanisms at the spinal cord level and supraspinal centers. It primarily acts by inhibiting the gamma efferent activity, thereby reducing the sensitivity of muscle spindles. This leads to a decrease in muscle reflex excitability and subsequent muscle relaxation. Eperisone also demonstrates inhibitory effects on both monosynaptic and polysynaptic reflexes, further contributing to its antispastic action. Additionally, it exhibits a vasodilatory effect on vascular smooth muscle, which helps to improve blood circulation, thereby potentially alleviating pain and facilitating muscle recovery in ischemic conditions. The drug is believed to modulate pain pathways and alleviate muscle stiffness by reducing muscle spasm and enhancing local blood flow, offering comprehensive relief for various musculoskeletal conditions.